Before-and-after study: Antimicrobial stewardship in high-risk febrile neutropenia patients reduced carbapenem and glycopeptide use and was associated with improved clinical outcomes.

Antimicrobial stewardship in high-risk febrile neutropenia patients – Antimicrobial Resistance & Infection Control

Related:

Safety and efficacy of antibiotic de-escalation and discontinuation in high-risk hematological patients with febrile neutropenia: a single-center experience.

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines – Annals of Oncology

Commentary from the author on Twitter (thread – click for more)

? Our new study "Antimicrobial stewardship in high-risk febrile neutropenia patients." is now out in #ARIC !?

Find our open access paper here: https://t.co/2fFoHfpEzi

And some data bellow ⬇️ (1/10) pic.twitter.com/kg4pYQs9HD

— Adrien Contejean (@AdrienContejean) March 29, 2022